Kranus Health
PrivateLast Round
Series A
Extension
Mar 25, 2024
Est. Valuation
$57.56M
Total Funding Raised
$21.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kranus Health operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Series A Extension round in March 2024.
Kranus Health is a healthtech company that provides a digital health platform with virtual care and therapies for urological conditions.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Medical Devices
Business Model
B2B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kranus Health Comparables
Compare Kranus Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sidekick Health | 85% | |
| HelloBetter | 82% | |
| MEDICE – The Health Family | 79% |
For institutional investors. Book with your work email.
Kranus Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 25, 2024 | ||||
| Series A Extension | Oct 2, 2023 | ||||
| Series A | Jun 21, 2022 | ||||
| Seed | Feb 4, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kranus Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CapHorn Invest | Series A Extension |
| Peak Pride | Series A, Series A Extension |
| Saarbruecker 21 | Series A Extension |
| SwissHealth Ventures | Series A Extension |
| Future Positive Capital | Series A Extension |
| Karista | Series A Extension, Series A |
| High-Tech Gründerfonds | Seed, Series A, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
Launched Kranus Mictera, a digital therapy for women.
- Jul 24, 2026
Grew 16% QoQ, from 62 to 72 employees.
For institutional investors. Book with your work email.
Kranus Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kranus Health's valuation, stock price, and market status.
Is Kranus Health a public or private company?
Kranus Health is a private company.
What is the current stock price of Kranus Health?
Kranus Health is a private company, so its shares have no public market price. Caplight tracks Kranus Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kranus Health worth (valuation)?
Kranus Health's valuation is estimated at $57.6M based on funding round data.
Can I buy Kranus Health stock?
Kranus Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kranus Health's last funding round?
Kranus Health's most recent funding round was Series A Extension on March 25, 2024.
Who are the main investors in Kranus Health?
Key investors in Kranus Health include CapHorn Invest, SwissHealth Ventures, Future Positive Capital, Karista.
Will Kranus Health IPO soon?
No public IPO plans have been announced for Kranus Health.
How can I track Kranus Health secondary market activity?
Caplight tracks bids, offers, and trades in Kranus Health's shares on secondary markets.